点击图片查看原图
Human EGF-receptor
1,2-丁酸-3-棕榈酸甘油酯
十一烷醇
通过常州国家高新区(新北区)市场监督管理局认证 
英国Kinasechem现货Ob
BX-912 CAS No. 70267
英国Kinasechem现货Im
英国Kinasechem现货PL| 货号： | MT0180 |
| 保存条件： | - 20℃ |
| CAS号： | 273404-37-8 |
| 供应商： | Meditech |
| 英文名： | VX-765 |
| 保质期： | 2年 |
| 规格： | 10mg |
纯度：>98%
描述：
S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765) is an orally absorbed prodrug of (S)-3-({1-[(S)-1-((S)-2-{[1-(4-amino-3-chlorophenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidin-2yl]-methanoyl}-amino)-4-oxo-butyric acid (VRT-043198), a potent and selective inhibitor of interleukin-converting enzyme/caspase-1 subfamily caspases. VRT-043198 exhibits 100- to 10,000-fold selectivity against other caspase-3 and -6 to -9. The therapeutic potential of VX-765 was assessed by determining the effects of VRT-043198 on cytokine release by monocytes in vitro and of orally administered VX-765 in several animal models in vivo. In cultures of peripheral blood mononuclear cells and whole blood from healthy subjects stimulated with bacterial products, VRT-043198 inhibited the release of interleukin (IL)-1beta and IL-18, but it had little effect on the release of several other cytokines, including IL-1alpha, tumor necrosis factor-alpha, IL-6 and IL-8. In contrast, VRT-043198 had little or no demonstrable activity in cellular models of apoptosis, and it did not affect the proliferation of activated primary T cells or T-cell lines. VX-765 was efficiently converted to VRT-043198 when administered orally to mice, and it inhibited lipopolysaccharide-induced cytokine secretion. In addition, VX-765 reduced disease severity and the expression of inflammatory mediators in models of rheumatoid arthritis and skin inflammation. [1]
参考文献：
[1] J Pharmacol Exp Ther. 2007; 321(2):509-16.
注意：
本产品仅用于科研！
若想获取更多产品信息，请登录！
http://www.meditechbs.com/
温馨提示：不可用于临床治疗。
